BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patel DN, Jha S, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Chapin BF, Freedland SJ. Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital. Int J Urol 2018;25:998-1004. [PMID: 30253446 DOI: 10.1111/iju.13806] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Alcaraz Asensio A, Alvarez Ossorio J, Cozar Olmo J, Chantada Abal V, Juarez Soto A, Linares Espinos E, Moreno Jimenez J, Muñoz Rodriguez J, Perez Fentes D, Plata Bello A, Rodrigo Aliaga M, Unda Urzaiz M, Vilaseca A. Cáncer de próstata resistente a la castración no metastásico: recomendaciones de manejo. Actas Urológicas Españolas 2022;46:193-213. [DOI: 10.1016/j.acuro.2021.11.004] [Reference Citation Analysis]
2 Koura M, Shiota M, Ueda S, Matsumoto T, Kobayashi S, Monji K, Kashiwagi E, Takeuchi A, Inokuchi J, Shiga KI, Yokomizo A, Eto M. Prognostic impact of prior local therapy in castration-resistant prostate cancer. Jpn J Clin Oncol 2021;51:1142-8. [PMID: 33621330 DOI: 10.1093/jjco/hyab019] [Reference Citation Analysis]
3 Nason GJ, Hamilton RJ. Treating the primary in metastatic prostate cancer: where do we stand? Current Opinion in Supportive & Palliative Care 2019;13:243-8. [DOI: 10.1097/spc.0000000000000432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Tablazon IL, Howard LE, De Hoedt AM, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Freedland SJ, Williams SB. Predictors of skeletal-related events and mortality in men with metastatic, castration-resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Cancer 2019;125:4003-10. [PMID: 31390061 DOI: 10.1002/cncr.32414] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
5 Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Mariya Y, Ohyama C. Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer. Clin Genitourin Cancer 2020;18:e523-30. [PMID: 32278839 DOI: 10.1016/j.clgc.2020.03.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]